BioNTech SE (BNTX)
85.04
-2.61
(-2.98%)
USD |
NASDAQ |
Nov 12, 16:00
84.88
-0.16
(-0.19%)
After-Hours: 06:50
BioNTech Shareholders Equity (Quarterly) : 20.12B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.12B |
| June 30, 2026 | 20.30B |
| March 31, 2026 | 21.54B |
| December 31, 2025 | 22.58B |
| September 30, 2025 | 21.71B |
| June 30, 2025 | 21.72B |
| March 31, 2025 | 20.44B |
| December 31, 2024 | 20.10B |
| September 30, 2024 | 21.33B |
| June 30, 2024 | 20.44B |
| March 31, 2024 | 21.57B |
| December 31, 2023 | 22.36B |
| September 30, 2023 | 21.03B |
| June 30, 2023 | 21.72B |
| Date | Value |
|---|---|
| March 31, 2023 | 22.02B |
| December 31, 2022 | 21.40B |
| September 30, 2022 | 17.99B |
| June 30, 2022 | 17.60B |
| March 31, 2022 | 17.70B |
| December 31, 2021 | 13.53B |
| September 30, 2021 | 10.10B |
| June 30, 2021 | 6.502B |
| March 31, 2021 | 2.961B |
| December 31, 2020 | 1.679B |
| September 30, 2020 | 1.088B |
| June 30, 2020 | 676.06M |
| March 31, 2020 | 491.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | 6.837B |
| Mereo BioPharma Group Plc | 23.71M |
| NuCana Plc | 26.89M |
| Immatics NV | 498.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.91B |
| Total Liabilities (Quarterly) | 2.797B |
| Debt to Equity Ratio | 0.0286 |
| Current Ratio | 8.552 |
| Net Debt Paydown Yield | -0.21% |